logo

Stock Screener

Forex Screener

Crypto Screener

CVS

CVS Health Corporation (CVS)

$

76.69

-0.63 (-0.82%)


Key metrics

Financial statements

Free cash flow per share

Free cash flow per share

6.1472

Market cap

Market cap

97.6 Billion

Price to sales ratio

Price to sales ratio

0.2427

Debt to equity

Debt to equity

1.2444

Current ratio

Current ratio

0.8424

Income quality

Income quality

3.6150

Average inventory

Average inventory

19.1 Billion

ROE

ROE

0.0234



Technology

Technology

Technology – consumer electronics

Largecap

Largecap

With a market cap of 121,78 bil stock is ranked 1

Low risk

Low risk

ISS score of this stock is ranked 1


Company description

Profile

CVS Health Corporation provides a comprehensive range of health services across the United States, demonstrating its commitment to meet the diverse needs of its clientele. The company’s Health Care Benefits segment offers a variety of health insurance products, including traditional, voluntary, and consumer-directed options, aimed at employer groups, individuals, college students, part-time workers, and various other organizations such as health plans and governmental units. With a net income ratio of 0.00 reflecting its profitability margin, CVS Health showcases its financial strength through an operating income of $10,385,000,000.00 indicative of its core operational earnings. The company earned an interest income of $0.00 showcasing its financial investments and ability to generate revenue outside its primary services. Additionally, the gross profit stands at $55,362,000,000.00 highlighting the effectiveness of its core operations. In its Pharmacy Services segment, CVS Health offers pharmacy benefit management solutions, including plan design, formulary management, and specialty pharmacy services, catering to a wide range of clients from employers to individuals. This segment plays a crucial role in managing medication needs and delivering tailored health care solutions. As of December 31, 2021, CVS Health operated approximately 9,900 retail locations and 1,200 MinuteClinic facilities, further affirming its extensive presence in the health care market. Within the financial landscape, CVS Health's stock is identified with the symbol 'CVS', attracting a variety of investors. The stock is affordable at $74.92 suitable for budget-conscious investors, while its high average trading volume of 8,406,913.00 indicates strong liquidity. With a large market capitalization of $97,565,784,900.00 the company stands as a dominant player in the health services industry, contributing significantly to the overall market landscape. As it belongs to the Healthcare sector, CVS Health is instrumental in driving innovation and growth, shaping the future of health care delivery and access. This strategic positioning not only enhances its market influence but also ensures it remains a pivotal force within the evolving health care industry.

What is CVS Health Corporation (CVS)'s current stock price?

The current stock price of CVS Health Corporation (CVS) is $76.69 as of 2026-02-20. Prices may fluctuate during the trading day. For real-time updates, check your brokerage platform or financial news websites.

Investing in CVS Health Corporation (CVS) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B, with a Bullish outlook. Always conduct your own research before investing.

Analysts predict CVS Health Corporation stock to fluctuate between $58.35 (low) and $85.15 (high) in the next 365 days, reflecting market expectations and potential volatility.

As of 2026-02-20, CVS Health Corporation's market cap is $97,565,784,900, based on 1,272,210,000 outstanding shares.

Compared to Eli Lilly & Co., CVS Health Corporation has a Lower Market-Cap, indicating a difference in performance.

CVS Health Corporation pays dividends. The current dividend yield is 3.22%, with a payout of $0.67 per share.

To buy CVS Health Corporation (CVS) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CVS. Place an order (Market, Limit, etc.).

The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.

CVS Health Corporation's last stock split was 2:1 on 2005-06-07.

Revenue: $402,067,000,000 | EPS: $1.40 | Growth: -61.75%.

Visit https://www.cvshealth.com/investor-relations for detailed financial reports.

You can explore historical data from here

All-time high: $111.25 (2022-02-08) | All-time low: $43.56 (2024-12-23).

Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.


News

CVS

zacks.com

Here's Why CVS Health (CVS) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

CVS

zacks.com

Here's Why CVS Health (CVS) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

CVS

globenewswire.com

Saggio Realty Announces Milestone Linked to Sale of Marco Island's CVS-Anchored Plaza

Mike Rivera Of Naples Fl Congratulates Hendricks Commercial Properties on Exceptional Return From Sale of Marco Island's CVS-Anchored Island Plaza Mike Rivera Of Naples Fl Congratulates Hendricks Commercial Properties on Exceptional Return From Sale of Marco Island's CVS-Anchored Island Plaza

CVS

benzinga.com

Analysts See Multiple Growth Levers For CVS Health In 2026

CVS Health Corp. (NYSE: CVS) reported sales of $105.69 billion, beating the consensus of $103.59 billion on Tuesday.

CVS

zacks.com

CVS Beats on Q4 Earnings and Revenues but Shares Slide in Pre-Market

CVS beats Q4 earnings and revenue estimates, but higher costs squeeze margins. Shares slip pre-market despite upbeat 2026 EPS guidance.

CVS

seekingalpha.com

CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript

CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript

CVS

zacks.com

CVS Health (CVS) Tops Q4 Earnings and Revenue Estimates

CVS Health (CVS) came out with quarterly earnings of $1.09 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $1.19 per share a year ago.

CVS

247wallst.com

The CVS Earnings Bombshell That Has Investors Scrambling Right Now

CVS Health (NYSE: CVS) delivered a solid revenue beat in Q4 2025, though adjusted earnings declined year-over-year despite exceeding Wall Street expectations.

CVS

barrons.com

CVS Stock Falls After Earnings Beat. Why Medicare Worries Persist.

CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates.

CVS

marketwatch.com

CVS Health's turnaround is paying off amid widespread changes to health insurance and retail pharmacy businesses

The healthcare giant saw its revenue jump 8% in the fourth quarter

See all news

logo
Stocks, Indicators, Pattern screeners all at one place
Stock Screener
Forex Screener
Crypto Screener